Risk stratification and preoperative evaluation of the patient with known or suspected liver disease
Stacey Prenner, Daniel Ganger – 27 May 2016
An ethical appraisal of financial incentives for organ donation
Saba S. Shaikh, Courtenay R. Bruce – 27 May 2016
Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinoma
Neehar D. Parikh, Amit G. Singal – 27 May 2016
Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinoma
Neehar D. Parikh, Amit G. Singal – 27 May 2016
Epidemiology of nonalcoholic fatty liver disease: A primer
Albert Do, Joseph K. Lim – 27 May 2016
Cardiopulmonary examination
Michael J. Krowka – 27 May 2016
Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end‐stage renal disease
Fernando Pedraza, Marco Ladino, David Roth – 27 May 2016
Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C
Kentaro Matsuura, Valeria De Giorgi, Cathy Schechterly, Richard Y. Wang, Patrizia Farci, Yasuhito Tanaka, Harvey J. Alter – 26 May 2016 – The goal of this study was to determine whether an association exists between circulating microRNA (miRNA) levels and disease progression in chronic hepatitis C (CHC), whether plasma or extracellular vesicles (EVs) were optimal for miRNA measurement and their correlation with hepatic miRNA expression, and the mechanistic plausibility of this association. We studied 130 CHC patients prospectively followed over several decades.
Editorial Board
26 May 2016
ISSN
26 May 2016